Allarity Therapeutics
ALLR
3 hedge funds and large institutions have $31.8K invested in Allarity Therapeutics in 2023 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 3 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
0.04% less ownership
Funds ownership: 0.04% → 0% (-0.04%)
50% less funds holding
Funds holding: 6 → 3 (-3)
94% less capital invested
Capital invested by funds: $516K → $31.8K (-$484K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TSS
Two Sigma Securities
New York
|
+$14.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$268K |
| 2 |
AC
Armistice Capital
New York
|
-$195K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$19.6K |
| 4 |
VF
Virtu Financial
New York
|
-$6.24K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
TSS
1
Two Sigma Securities
New York
| $20.7K | +$14.6K | +42 | +200% |
|
|
VF
2
Virtu Financial
New York
| $8K | -$6.24K | -18 | -42% |
|
|
TRCT
3
Tower Research Capital (TRC)
New York
| $3.05K | – | – | – |
|
4
Wells Fargo
San Francisco,
California
| $18 | – | – | – |
|
|
SM
5
Sabby Management
Miami Beach,
Florida
| – | -$268K | -599 | Closed |
|
|
AC
6
Armistice Capital
New York
| – | -$195K | -435 | Closed |
|
|
7
Citadel Advisors
Miami,
Florida
| – | -$19.6K | -44 | Closed |
|
ALLR Hedge Fund Activity: Q4 2023 in Review
3 of the 6,864 institutional investors tracked by Wall St. Rank reported a position in Allarity Therapeutics (ALLR) for Q4 2023, worth a combined $31.8K — down 94% from $516K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of ALLR and 0 opened new positions — a net loss of 3 holders — while 1 trimmed existing stakes and 1 added.
The largest buyer was Two Sigma Securities, adding an estimated $14.6K. The largest seller was Sabby Management, exiting entirely with an estimated $268K sold.
- 3 institutional investors held Allarity Therapeutics (ALLR) as of Q4 2023, down from 6 in Q3 2023.
- Funds reported $31.8K of Allarity Therapeutics stock for Q4 2023, down 94% quarter-over-quarter.
- 0 funds opened new Allarity Therapeutics positions in Q4 2023 and 3 closed out, a net change of -3 holders.
- The largest Allarity Therapeutics buyer in Q4 2023 was Two Sigma Securities, an estimated $14.6K added.
- The largest Allarity Therapeutics seller in Q4 2023 was Sabby Management, an estimated $268K sold.
Based on aggregated 13F filings for Q4 2023.